Matches in Wikidata for { <http://www.wikidata.org/entity/Q94154208> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q94154208 description "article scientifique publié en 2018" @default.
- Q94154208 description "wetenschappelijk artikel" @default.
- Q94154208 description "наукова стаття" @default.
- Q94154208 name "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 name "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 type Item @default.
- Q94154208 label "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 label "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 prefLabel "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 prefLabel "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 P1433 Q94154208-BF5DD48E-406F-47A1-97AF-87C756B47396 @default.
- Q94154208 P1476 Q94154208-B73984A6-B7CA-4DAC-80B0-115370972B0D @default.
- Q94154208 P2093 Q94154208-1E048D8C-8D3A-43BF-B129-1234E6B1D3E2 @default.
- Q94154208 P2093 Q94154208-2CC80F07-AEB5-4343-82F3-16F6E091B64A @default.
- Q94154208 P2093 Q94154208-4279FF3A-80D1-405F-A2A4-413F01486EF9 @default.
- Q94154208 P2093 Q94154208-47122E4D-6F04-4D3B-9263-CC9DBB7ACA71 @default.
- Q94154208 P2093 Q94154208-8EEC9C4F-BEC0-41B8-89A6-34B93BD7EABE @default.
- Q94154208 P2093 Q94154208-9DCC60F0-6498-4768-9C18-9E9FCC672E02 @default.
- Q94154208 P2093 Q94154208-AF02A951-F51D-4775-A26C-1178F7BE5FB0 @default.
- Q94154208 P2093 Q94154208-C1E291DE-214E-4C2A-A0C5-A2C534E33E19 @default.
- Q94154208 P2093 Q94154208-D1DD428E-3D49-4BF1-BF27-506273EAF64E @default.
- Q94154208 P2093 Q94154208-DF1E64C8-E02F-4904-AF6B-551F54BC81CA @default.
- Q94154208 P2093 Q94154208-EF567B8F-E63F-4095-B56E-BCAA21B9E7C5 @default.
- Q94154208 P2093 Q94154208-F98DF79C-801B-4D76-8689-752AD9D50EA2 @default.
- Q94154208 P304 Q94154208-32974AC8-77EE-4C0D-8651-DAC81B8804BD @default.
- Q94154208 P31 Q94154208-C5DDD448-0D3F-499B-A99C-C32C6C8E401F @default.
- Q94154208 P356 Q94154208-61488FBE-59F5-45AB-AF73-688EFD1F5A76 @default.
- Q94154208 P433 Q94154208-D26D7003-78AD-4A62-A42E-509D8F49AA1D @default.
- Q94154208 P478 Q94154208-DFDFDCB8-7C50-4C42-A44A-2F9A56DF456E @default.
- Q94154208 P50 Q94154208-28975091-2451-459C-BBF3-58C5BD67A325 @default.
- Q94154208 P50 Q94154208-9CD7C681-36A4-4F7D-A660-0F77498D2FFF @default.
- Q94154208 P577 Q94154208-B77FC575-27C7-481B-AD15-52DB7F84AC1E @default.
- Q94154208 P921 Q94154208-4B7DDC08-C3FA-4D5E-8E7F-7B75A0CC21FD @default.
- Q94154208 P921 Q94154208-CCFCFE98-B1C2-442C-AAC2-EB2D33D7ADF5 @default.
- Q94154208 P921 Q94154208-DE36FEFC-8439-40D4-84D9-5B93C404D56E @default.
- Q94154208 P932 Q94154208-6387F0AB-A446-48B6-B542-BAC89E81876E @default.
- Q94154208 P356 NOY148.998 @default.
- Q94154208 P1433 Q15724471 @default.
- Q94154208 P1476 "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB" @default.
- Q94154208 P2093 "Antonio Omuro" @default.
- Q94154208 P2093 "Elizabeth Gerstner" @default.
- Q94154208 P2093 "Elizabeth Vera" @default.
- Q94154208 P2093 "Frank Lieberman" @default.
- Q94154208 P2093 "H Robins" @default.
- Q94154208 P2093 "Jimin Wu" @default.
- Q94154208 P2093 "Jing Wu" @default.
- Q94154208 P2093 "Kenneth Aldape" @default.
- Q94154208 P2093 "Mark Gilbert" @default.
- Q94154208 P2093 "Terri Armstrong" @default.
- Q94154208 P2093 "Tito Mendoza" @default.
- Q94154208 P2093 "Ying Yuan" @default.
- Q94154208 P304 "vi241-vi241" @default.
- Q94154208 P31 Q13442814 @default.
- Q94154208 P356 "10.1093/NEUONC/NOY148.998" @default.
- Q94154208 P433 "Suppl 6" @default.
- Q94154208 P478 "20" @default.
- Q94154208 P50 Q105531697 @default.
- Q94154208 P50 Q47159896 @default.
- Q94154208 P577 "2018-11-05T00:00:00Z" @default.
- Q94154208 P921 Q1346753 @default.
- Q94154208 P921 Q425088 @default.
- Q94154208 P921 Q7159224 @default.
- Q94154208 P932 "6217700" @default.